108 related articles for article (PubMed ID: 1530374)
1. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.
Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA
Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):18-24. PubMed ID: 1383627
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new cardiotonic phosphodiesterase inhibitor 1,2-dihydro-5- imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3-pyridine-carbonitrile hydrochloride monohydrate on aortic input impedance.
Kubota T; Itaya R; Todaka K; Sugimachi M; Sunagawa K; Takeshita A
Arzneimittelforschung; 1991 Dec; 41(12):1211-5. PubMed ID: 1815518
[TBL] [Abstract][Full Text] [Related]
10. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
[TBL] [Abstract][Full Text] [Related]
11. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic profile of the cardiotonic agent pimobendan.
van Meel JC; Diederen W
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
Dage RC; Roebel LE; Hsieh CP; Woodward JK
J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
[TBL] [Abstract][Full Text] [Related]
15. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
[TBL] [Abstract][Full Text] [Related]
16. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
Makela VH; Kapur PA
Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
Beyer ME; Hoffmeister HM; Seipel L
J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of R 80122 immediately after cardiopulmonary bypass; preliminary results.
Herregods L; Rolly G; Van Belleghem Y; Van Nooten G
Anaesthesia; 1994 Aug; 49(8):719-22. PubMed ID: 7943708
[TBL] [Abstract][Full Text] [Related]
19. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of direct effects of enoximone on systemic and pulmonary vascular bed in animals with a Jarvik total artificial heart.
Deleuze PH; Rande JL; Okude J; Wan F; Brunet S; Thoraval FR; Cachera JP; Loisance DY
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):589-94. PubMed ID: 1532041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
